Want to see HK:1931 full AI Analyst Report?
1931 Stock Chart & Stats
HK$3.85
HK$0.05(2.67%)
At close: 4:00 PM EST
HK$3.85
HK$0.05(2.67%)
Day’s Range― - ―
52-Week RangeHK$0.56 - HK$12.86
Previous CloseN/A
Volume18.00K
Average Volume (3M)1.48M
Market Cap
HK$940.46M
Enterprise ValueHK$2.33B
Total Cash (Recent Filing)HK$551.05M
Total Debt (Recent Filing)HK$1.93B
Price to Earnings (P/E)23.2
Beta0.54
Next Earnings
Aug 14, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.81%
Share Statistics
EPS (TTM)0.02
Shares Outstanding1,621,488,000
10 Day Avg. Volume1,443,300
30 Day Avg. Volume1,483,483
Financial Highlights & Ratios
PEG Ratio-1.25
Price to Book (P/B)1.29
Price to Sales (P/S)1.35
P/FCF Ratio-3.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Historical Operating StrengthFrom 2021–2024 the company sustained healthy operating margins and positive growth, evidencing a viable distribution model and operational competence. That track record supports the view that prior operating leverage and cash generation can re-emerge if 2025 pressures are cyclical rather than structural.
Sizable Equity BufferDespite 2025 deterioration, the balance sheet still shows a sizable equity base, offering a capital cushion against insolvency risk. This buffer improves the company's ability to absorb losses, access financing on reasonable terms, and maintain operations while management executes remediation or working-capital fixes.
Low Volatility & Defensive IndustryA low beta (~0.54) and a presence in medical distribution suggest lower share and revenue volatility versus cyclical peers. Structural healthcare demand and recurring distribution relationships can help stabilize sales and cash flows over the medium term, aiding recovery and planning.
Bears Say
Cash-flow CollapseOperating cash flow swung deeply negative (-919M) and free cash flow to about -1.01B in 2025, reversing prior positive generation. Such a large cash outflow heightens near-term liquidity and funding risk, constrains investment and debt service, and forces reliance on external financing if not remediated.
Severe Margin DeteriorationRevenue declined roughly 11% while net margin compressed to ~1.2% from ~8.2%, representing a meaningful earnings reset. Persistently weak margins reduce internal cash generation and competitiveness, increasing sensitivity to pricing, cost inflation, and limiting ability to rebuild profitability without structural changes.
Rising LeverageDebt-to-equity increasing to ~0.62 from ~0.20 materially reduces financial flexibility. Higher leverage elevates interest burden, restricts capacity to fund working capital or strategic initiatives internally, and raises refinancing and covenant risks if cash flows do not recover in the medium term.
IVD Medical Holding Limited News
1931 FAQ
What was IVD Medical Holding Limited’s price range in the past 12 months?
IVD Medical Holding Limited lowest stock price was HK$0.56 and its highest was HK$12.86 in the past 12 months.
What is IVD Medical Holding Limited’s market cap?
IVD Medical Holding Limited’s market cap is HK$940.46M.
When is IVD Medical Holding Limited’s upcoming earnings report date?
IVD Medical Holding Limited’s upcoming earnings report date is Aug 14, 2026 which is in 11 days.
How were IVD Medical Holding Limited’s earnings last quarter?
IVD Medical Holding Limited released its earnings results on Mar 27, 2026. The company reported -HK$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.003.
Is IVD Medical Holding Limited overvalued?
According to Wall Street analysts IVD Medical Holding Limited’s price is currently Overvalued.
Does IVD Medical Holding Limited pay dividends?
IVD Medical Holding Limited pays a Notavailable dividend of HK$0.062 which represents an annual dividend yield of 3.81%. See more information on IVD Medical Holding Limited dividends here
What is IVD Medical Holding Limited’s EPS estimate?
IVD Medical Holding Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does IVD Medical Holding Limited have?
IVD Medical Holding Limited has 1,621,488,000 shares outstanding.
What happened to IVD Medical Holding Limited’s price movement after its last earnings report?
IVD Medical Holding Limited reported an EPS of -HK$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.893%.
Which hedge fund is a major shareholder of IVD Medical Holding Limited?
Currently, no hedge funds are holding shares in HK:1931
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
IVD Medical Holding Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
320.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
12.45%
Trailing 12-Months
Company Description
IVD Medical Holding Limited
null
Technical Analysis
China Health Group
―
Shanghai Pharmaceuticals Holding Co
―
Sinopharm Group Co
―
Medlive Technology Co., Ltd.
―
Charmacy Pharmaceutical Co., Ltd. Class H
―